Le Lézard
Classified in: Health, Science and technology
Subject: PDT

PeploBio and IncellDX Partner to Launch the First Long COVID Test in the UK and EU


GUILDFORD, England and HAYWARD, Calif., April 17, 2024 /PRNewswire/ -- PeploBio and IncellDX are launching the first laboratory developed test in the UK and EU to help diagnose Long COVID, providing doctors with accurate insights into personalised treatment approaches using the incellKINE Long Hauler Index technology.

Long COVID affects more than 65 million worldwide. The typical symptoms of Long COVID, ranging from fatigue, brain fog, shortness of breath, insomnia, to a spectrum of cardiovascular issues, are not exclusive to any single condition. This technological breakthrough aims to provide physicians with a definitive tool to differentiate Long COVID from other diseases sharing similar symptoms such as Lyme and ME-CFS.  

"Our collaboration with PeploBio marks a pivotal moment in the battle against Long COVID. The incellKINE Long Hauler Index technology enables us to identify a distinctive immunologic profile unique to Long COVID patients, providing a crucial first step for personalised treatment strategies," said Bruce Patterson, M.D., Founder and CEO at IncellDX. 

Dr. Nico Lambri, Managing Director at PeploBio said, "Our mission at PeploBio is to drive innovation in diagnostics, and our partnership with IncellDX underscores our commitment to advancing healthcare solutions. The introduction of this test fills a critical gap, empowering healthcare professionals with the tools needed to address the challenges posed by Long COVID." 

About PeploBio 

PeploBio is an ISO 15189 accredited clinical laboratory, committed to elevating precision medicine and bringing innovative diagnostic solutions to improve patient outcomes. 

About IncellDX 

IncellDx is a precision medicine company advancing novel diagnostics and prognostics to better understand and treat infectious disease and cancer. The company's innovative technology platform enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers. 

For media enquiries, please contact: 

PeploBio:

IncellDX: 

Jack Purvis  

Julie Ferguson 

[email protected]

JFPRMEDIAGROUP 

+44 (0)1483 685 190

[email protected]


(312) 385-0098

SOURCE PeploBio


These press releases may also interest you

at 15:13
Honeywell Report Reveals "Silent Residency" Is Driving Escalating Cyber Threat for Industrial and Critical Infrastructure Facilities
Honeywell today released its 2024 USB Threat Report, which provides new insight into how "silent residency" is an increasing cyber threat for industrial and critical infrastructure facilities. In the report, Honeywell highlighted the growing risk of...

at 15:13
Tesseract Ventures Announces Revolutionary SWARM Drone Technology for Special Operations Forces
Tesseract Ventures is excited to announce that it has been awarded an Other Transaction Agreement (OTA) from the U.S. Special Operations Command (USSOCOM). This contract will fund the development of the company's next-generation drone, the SWARM...

at 15:05
EY Announces Kevin Gosschalk of Arkose Labs as an Entrepreneur Of The Year® 2024 Bay Area Award Finalist
Ernst & Young LLP (EY US) today announced that Arkose Labs Founder and CEO Kevin Gosschalk was named an Entrepreneur Of The Year® 2024 Bay Area Award finalist. Now in its 38th year, Entrepreneur Of The Year is the preeminent competitive business...

at 15:00
Nick Cannon, Cam'ron, Shaunie Henderson & Others Join the Lineup for the 2024 BLACK ENTERPRISE Disruptor Summit in Atlanta
Today, BLACK ENTERPRISE, the nation's leading Black digital media brand, is excited to announce the return of the highly anticipated 2nd annual Disruptor Summit, a creative business conference designed to empower Black entrepreneurs, innovators, and...

at 14:40
BBB National Programs Applauds Today's Launch of the Global CBPR Forum, Strengthening Commitments to International Data Privacy
BBB National Programs applauds the work of the U.S. Department of Commerce to launch the Global Cross Border Privacy Rules (CBPR) Forum, a key development in international cooperation on cross-border data flows....

at 14:38
EDETEK to Present Keynote Presentation at 15th Clinical Trials Strategic Summit
EDETEK Inc., a leading global provider of comprehensive, fully integrated platforms and services for clinical development across the biopharma, medical devices, and diagnostics industries, announced today that it will be a platinum sponsor and...

More news about Science and technology...


News published on and distributed by: